home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Astrocytes Kill Neurons In ALS

  April, 19 2007 8:29
your information resource in human molecular genetics
Astrocytes carrying a mutated version of a protein that causes amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease) are responsible for the death of motor neurons, report two papers in the May 2007 issue of Nature Neuroscience. These findings suggest that stem cell therapy focused on replacing damaged neurons may not be feasible in ALS, because diseased astrocytes would be expected to damage the replacement neurons.

Mutations in the gene for superoxide dismutase (SOD1) cause some
cases of ALS, in which progressive degeneration of motor neurons leads to paralysis and eventually death. In both studies, the authors expressed this mutant protein in single cell types in culture. Motor neurons degenerated and died when cocultured with astrocytes expressing mutant SOD1, while mutant SOD1 in neurons, fibroblasts or microglia did not cause neuronal death.

Przedborski and colleagues additionally report that the astrocytes expressing mutant SOD1 killed only the neurons that degenerate in ALS, not other types of neurons, and that this was due to a soluble toxic factor released by the astrocytes. If this toxic factor can be identified in future studies, this finding may offer novel strategies for therapy.

Author contacts:

Serge Przedborski (Columbia University, New York, NY, USA)
E-mail: sp30@columbia.edu

Kevin Eggan (Harvard University, Cambridge, MA USA)
E-mail: eggan@mcb.harvard.edu

Additional contact for comment on paper:

Jean-Pierre Julien (Laval University, Québec, Canada)
E-mail: jean-pierre.julien@crchul.ulaval.ca

Abstracts available online:
Paper 1.
Paper 2.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.